Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid

ObjectivesBullous pemphigoid (BP) is a prototypical autoimmune disease characterized by the production of autoantibodies against hemidesmosomal proteins BP180 and BP230. Aberrant glycosylation has emerged as a possible mechanism linked to the pathogenesis and progression of autoimmune diseases. Howe...

Full description

Saved in:
Bibliographic Details
Main Authors: Haijun Miao, Jundan Yang, Yaxing Bai, Shengxian Shen, Xia Li, Lixin Yue, Gang Wang, Erle Dang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1538126/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849325436184559616
author Haijun Miao
Jundan Yang
Yaxing Bai
Shengxian Shen
Xia Li
Lixin Yue
Gang Wang
Erle Dang
author_facet Haijun Miao
Jundan Yang
Yaxing Bai
Shengxian Shen
Xia Li
Lixin Yue
Gang Wang
Erle Dang
author_sort Haijun Miao
collection DOAJ
description ObjectivesBullous pemphigoid (BP) is a prototypical autoimmune disease characterized by the production of autoantibodies against hemidesmosomal proteins BP180 and BP230. Aberrant glycosylation has emerged as a possible mechanism linked to the pathogenesis and progression of autoimmune diseases. However, the precise alterations in glycosylation in BP remain largely unknown. In this study, we explored the molecular mechanisms of abnormal glycosylation in BP pathogenesis.MethodsWe systematically investigated the glycosylation changes in serum, blister fluid, and saliva from BP patients using lectin microarray assays and lectin-based enzyme-linked immunosorbent assays.ResultsOur findings revealed increased glycosylation modifications of sialic acid, galactose, and fucose in serum proteins from BP patients, as well as enhanced fucosylation, galactosylation, and biantennary N-glycan glycosylation in blister fluid proteins. Notably, these abnormal modifications of monosaccharides correlated with the clinical indicators of BP. Furthermore, we observed that glycosylation patterns in saliva were associated with disease severity, suggesting their potential as valuable non-invasive diagnostic markers for BP.ConclusionThese discoveries indicate that aberrant glycosylation patterns may provide insights into the pathogenesis of BP and serve as potential biomarkers for diagnosing and monitoring the disease.
format Article
id doaj-art-cd511b817b5f4683bdebab46f21f92d8
institution Kabale University
issn 1664-3224
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-cd511b817b5f4683bdebab46f21f92d82025-08-20T03:48:23ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-05-011610.3389/fimmu.2025.15381261538126Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoidHaijun MiaoJundan YangYaxing BaiShengxian ShenXia LiLixin YueGang WangErle DangObjectivesBullous pemphigoid (BP) is a prototypical autoimmune disease characterized by the production of autoantibodies against hemidesmosomal proteins BP180 and BP230. Aberrant glycosylation has emerged as a possible mechanism linked to the pathogenesis and progression of autoimmune diseases. However, the precise alterations in glycosylation in BP remain largely unknown. In this study, we explored the molecular mechanisms of abnormal glycosylation in BP pathogenesis.MethodsWe systematically investigated the glycosylation changes in serum, blister fluid, and saliva from BP patients using lectin microarray assays and lectin-based enzyme-linked immunosorbent assays.ResultsOur findings revealed increased glycosylation modifications of sialic acid, galactose, and fucose in serum proteins from BP patients, as well as enhanced fucosylation, galactosylation, and biantennary N-glycan glycosylation in blister fluid proteins. Notably, these abnormal modifications of monosaccharides correlated with the clinical indicators of BP. Furthermore, we observed that glycosylation patterns in saliva were associated with disease severity, suggesting their potential as valuable non-invasive diagnostic markers for BP.ConclusionThese discoveries indicate that aberrant glycosylation patterns may provide insights into the pathogenesis of BP and serve as potential biomarkers for diagnosing and monitoring the disease.https://www.frontiersin.org/articles/10.3389/fimmu.2025.1538126/fullbullous pemphigoidglycosylationsialic acidfucoselectin/glyco-antibody microarrays
spellingShingle Haijun Miao
Jundan Yang
Yaxing Bai
Shengxian Shen
Xia Li
Lixin Yue
Gang Wang
Erle Dang
Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid
Frontiers in Immunology
bullous pemphigoid
glycosylation
sialic acid
fucose
lectin/glyco-antibody microarrays
title Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid
title_full Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid
title_fullStr Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid
title_full_unstemmed Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid
title_short Aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid
title_sort aberrant glycosylation patterns as potential biomarkers for diagnosis and disease progression in bullous pemphigoid
topic bullous pemphigoid
glycosylation
sialic acid
fucose
lectin/glyco-antibody microarrays
url https://www.frontiersin.org/articles/10.3389/fimmu.2025.1538126/full
work_keys_str_mv AT haijunmiao aberrantglycosylationpatternsaspotentialbiomarkersfordiagnosisanddiseaseprogressioninbullouspemphigoid
AT jundanyang aberrantglycosylationpatternsaspotentialbiomarkersfordiagnosisanddiseaseprogressioninbullouspemphigoid
AT yaxingbai aberrantglycosylationpatternsaspotentialbiomarkersfordiagnosisanddiseaseprogressioninbullouspemphigoid
AT shengxianshen aberrantglycosylationpatternsaspotentialbiomarkersfordiagnosisanddiseaseprogressioninbullouspemphigoid
AT xiali aberrantglycosylationpatternsaspotentialbiomarkersfordiagnosisanddiseaseprogressioninbullouspemphigoid
AT lixinyue aberrantglycosylationpatternsaspotentialbiomarkersfordiagnosisanddiseaseprogressioninbullouspemphigoid
AT gangwang aberrantglycosylationpatternsaspotentialbiomarkersfordiagnosisanddiseaseprogressioninbullouspemphigoid
AT erledang aberrantglycosylationpatternsaspotentialbiomarkersfordiagnosisanddiseaseprogressioninbullouspemphigoid